Comparable results of surgical versus non-surgical management for patients with malignant bowel obstruction-a lesson from S1316 study  

作　　者：Abdallah Al Farai Mansour Al Moundhri 

机构地区：[1]GI Program,Sultan Comprehensive Cancer Care and Research Center,Muscat,Oman

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第2期304-306,共3页肝胆外科与营养（英文）

摘　　要：We had the pleasure to read the paper published online by Krouse et al.in August 2023 in the Lancet Gastroenterology and Hepatology(1).The study labeled as S1316 was a prospective pragmatic comparative effectiveness trial evaluating the surgical versus non-surgical management for patients with malignant small intestinal bowel obstruction(MIO)and having an intra-abdominal or retroperitoneal primary cancer and were aged 18 years or older with a Zubrod performance status 0-2 within 1 week before admission;had a surgical indication;and treatment equipoise.The patients were divided in two pathways.Those who accepted the randomization were randomly assigned to surgical and non-surgical treatment groups.Those who declined consent for random assignment were offered a prospective observational patient choice pathway where the patients with their caring team decide upon the treatment option.

关 键 词：Malignant bowel obstruction SURGERY NON-SURGICAL 

分 类 号：R574.2[医药卫生—消化系统]